Clinical Trial Update: A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature [Phase 2]

View source ↗

Summary

A study extension update for a Phase 2 trial of PEG-somatropin in children with idiopathic short stature; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Short Stature

Drugs mentioned

• PEG-somatropin (pegylated somatropin)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Dwarfism | Phase 2 | Status: ACTIVE_NOT_RECRUITING